0 XP   0   0   0

Premier Biomedical Inc
Buy, Hold or Sell?

Should you buy, hold or sell Premier Biomedical Inc?

I guess you are interested in Premier Biomedical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Premier Biomedical Inc

Let's start. I'm going to help you getting a better view of Premier Biomedical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Premier Biomedical Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Premier Biomedical Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Premier Biomedical Inc. The closing price on 2023-02-03 was $0.0047 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Premier Biomedical Inc Daily Candlestick Chart
Premier Biomedical Inc Daily Candlestick Chart
Summary









1. Valuation of Premier Biomedical Inc




Current price per share

$0.00

2. Growth of Premier Biomedical Inc




Is Premier Biomedical Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.8m-$2.1m$314.5k17.2%

How much money is Premier Biomedical Inc making?

Current yearPrevious yearGrowGrow %
Making money-$374.4k-$398.8k$24.4k6.5%
Net Profit Margin-2,622.2%-1,002.4%--

How much money comes from the company's main activities?

3. Financial Health of Premier Biomedical Inc




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

1.1. Profitability of Premier Biomedical Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Premier Biomedical Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -2,622.2% means that $-26.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Premier Biomedical Inc:

  • The MRQ is -2,622.2%. The company is making a huge loss. -2
  • The TTM is -2,622.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,622.2%TTM-2,622.2%0.0%
TTM-2,622.2%YOY-1,002.4%-1,619.8%
TTM-2,622.2%5Y-2,618.0%-4.2%
5Y-2,618.0%10Y-1,636.2%-981.7%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,622.2%0.4%-2,622.6%
TTM-2,622.2%0.3%-2,622.5%
YOY-1,002.4%0.2%-1,002.6%
5Y-2,618.0%-0.7%-2,617.3%
10Y-1,636.2%-0.1%-1,636.1%
1.1.2. Return on Assets

Shows how efficient Premier Biomedical Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -371.0% Return on Assets means that Premier Biomedical Inc generated $-3.71 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Premier Biomedical Inc:

  • The MRQ is -371.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -371.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-371.0%TTM-371.0%0.0%
TTM-371.0%YOY-241.8%-129.2%
TTM-371.0%5Y-2,468.9%+2,098.0%
5Y-2,468.9%10Y-1,688.8%-780.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-371.0%0.1%-371.1%
TTM-371.0%0.1%-371.1%
YOY-241.8%-0.1%-241.7%
5Y-2,468.9%-0.2%-2,468.7%
10Y-1,688.8%0.1%-1,688.9%
1.1.3. Return on Equity

Shows how efficient Premier Biomedical Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • 0.0% Return on Equity means Premier Biomedical Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Premier Biomedical Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-0.6%
TTM-0.4%-0.4%
YOY-0.4%-0.4%
5Y--0.3%+0.3%
10Y-0.1%-0.1%

1.2. Operating Efficiency of Premier Biomedical Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Premier Biomedical Inc is operating .

  • Measures how much profit Premier Biomedical Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -2,287.9% means the company generated $-22.88  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Premier Biomedical Inc:

  • The MRQ is -2,287.9%. The company is operating very inefficient. -2
  • The TTM is -2,287.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,287.9%TTM-2,287.9%0.0%
TTM-2,287.9%YOY-1,741.0%-546.9%
TTM-2,287.9%5Y-1,454.6%-833.3%
5Y-1,454.6%10Y-909.1%-545.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,287.9%2.5%-2,290.4%
TTM-2,287.9%1.6%-2,289.5%
YOY-1,741.0%2.7%-1,743.7%
5Y-1,454.6%1.8%-1,456.4%
10Y-909.1%0.8%-909.9%
1.2.2. Operating Ratio

Measures how efficient Premier Biomedical Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 24.78 means that the operating costs are $24.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Premier Biomedical Inc:

  • The MRQ is 24.779. The company is inefficient in keeping operating costs low. -1
  • The TTM is 24.779. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ24.779TTM24.7790.000
TTM24.779YOY21.909+2.871
TTM24.7795Y16.154+8.626
5Y16.15410Y10.096+6.058
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ24.7791.473+23.306
TTM24.7791.456+23.323
YOY21.9091.398+20.511
5Y16.1541.374+14.780
10Y10.0961.191+8.905

1.3. Liquidity of Premier Biomedical Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Premier Biomedical Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.05 means the company has $0.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Premier Biomedical Inc:

  • The MRQ is 0.048. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.048. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.048TTM0.0480.000
TTM0.048YOY0.069-0.021
TTM0.0485Y0.066-0.018
5Y0.06610Y0.118-0.052
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0481.880-1.832
TTM0.0481.901-1.853
YOY0.0692.112-2.043
5Y0.0662.182-2.116
10Y0.1181.891-1.773
1.3.2. Quick Ratio

Measures if Premier Biomedical Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Premier Biomedical Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.0010.000
TTM0.0015Y0.001+0.001
5Y0.00110Y0.000+0.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0010.733-0.732
TTM0.0010.796-0.795
YOY0.0010.808-0.807
5Y0.0010.834-0.833
10Y0.0000.821-0.821

1.4. Solvency of Premier Biomedical Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Premier Biomedical Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Premier Biomedical Inc to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 19.16 means that Premier Biomedical Inc assets are financed with 1,915.7% credit (debt) and the remaining percentage (100% - 1,915.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Premier Biomedical Inc:

  • The MRQ is 19.157. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 19.157. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ19.157TTM19.1570.000
TTM19.157YOY14.015+5.142
TTM19.1575Y14.888+4.269
5Y14.88810Y11.215+3.673
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ19.1570.437+18.720
TTM19.1570.424+18.733
YOY14.0150.398+13.617
5Y14.8880.398+14.490
10Y11.2150.401+10.814
1.4.2. Debt to Equity Ratio

Measures if Premier Biomedical Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Premier Biomedical Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.652-0.652
TTM-0.675-0.675
YOY-0.623-0.623
5Y-0.684-0.684
10Y-0.697-0.697

2. Market Valuation of Premier Biomedical Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Premier Biomedical Inc generates.

  • Above 15 is considered overpriced but always compare Premier Biomedical Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -1.07 means the investor is paying $-1.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Premier Biomedical Inc:

  • The EOD is -12.551. Company is losing money. -2
  • The MRQ is -1.068. Company is losing money. -2
  • The TTM is -1.068. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-12.551MRQ-1.068-11.483
MRQ-1.068TTM-1.0680.000
TTM-1.068YOY-152.923+151.855
TTM-1.0685Y-1,013.341+1,012.273
5Y-1,013.34110Y-3,070.347+2,057.006
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-12.551-0.124-12.427
MRQ-1.068-0.437-0.631
TTM-1.068-0.102-0.966
YOY-152.92315.340-168.263
5Y-1,013.3417.916-1,021.257
10Y-3,070.3477.700-3,078.047
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Premier Biomedical Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Premier Biomedical Inc:

  • The MRQ is -1.007. Very Bad. -2
  • The TTM is -1.007. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-1.007TTM-1.0070.000
TTM-1.007YOY-80.740+79.734
TTM-1.0075Y-4,770.762+4,769.755
5Y-4,770.76210Y-4,770.7620.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.0070.012-1.019
TTM-1.0070.010-1.017
YOY-80.7400.004-80.744
5Y-4,770.7620.010-4,770.772
10Y-4,770.7620.021-4,770.783

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Premier Biomedical Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of -0.22 means the investor is paying $-0.22 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Premier Biomedical Inc:

  • The EOD is -2.564. Bad. Book ratio is negative. -2
  • The MRQ is -0.218. Bad. Book ratio is negative. -2
  • The TTM is -0.218. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-2.564MRQ-0.218-2.346
MRQ-0.218TTM-0.2180.000
TTM-0.218YOY-28.406+28.188
TTM-0.2185Y-5,277.809+5,277.591
5Y-5,277.80910Y-518,536.099+513,258.289
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-2.5641.415-3.979
MRQ-0.2181.586-1.804
TTM-0.2182.019-2.237
YOY-28.4062.230-30.636
5Y-5,277.8091.895-5,279.704
10Y-518,536.0991.505-518,537.604
2. Total Gains per Share

2.4. Latest News of Premier Biomedical Inc

Does Premier Biomedical Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Premier Biomedical Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-19
14:30
Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova Graphene Ballistics, Inc., Releases its Graphene Ballistic Plate Production ApproachRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Premier Biomedical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%0.000-32%0.000+212%0.000+173%
Book Value Growth--1.1461.1460%1.177-3%-0.706+162%-0.440+138%
Book Value Per Share---0.002-0.0020%-0.002+17%-0.002-16%-0.001-45%
Book Value Per Share Growth--1.1461.1460%1.177-3%-0.706+162%-0.440+138%
Current Ratio--0.0480.0480%0.069-30%0.066-27%0.118-59%
Debt To Asset Ratio--19.15719.1570%14.015+37%14.888+29%11.215+71%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.0000%0.000+7%-0.002+376%-0.001+244%
Eps Growth--1.0611.0610%1.894-44%0.861+23%0.861+23%
Free Cash Flow Per Share--0.0000.0000%0.000+28%0.000+30%0.000+39%
Free Cash Flow Per Share Growth--1.2191.2190%1.127+8%1.105+10%1.105+10%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-600%0.000-55%0.000-280%
Free Cash Flow To Equity Per Share Growth---5.005-5.0050%0.051-9918%0.554-1003%0.554-1003%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.750+33%
Intrinsic Value_10Y_max---0.004--------
Intrinsic Value_10Y_min---0.003--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max---0.001--------
Intrinsic Value_3Y_min---0.001--------
Intrinsic Value_5Y_max---0.002--------
Intrinsic Value_5Y_min---0.002--------
Net Profit Margin---26.222-26.2220%-10.024-62%-26.1800%-16.362-38%
Operating Margin---22.879-22.8790%-17.410-24%-14.546-36%-9.091-60%
Operating Ratio--24.77924.7790%21.909+13%16.154+53%10.096+145%
Pb Ratio-2.564-1075%-0.218-0.2180%-28.406+12916%-5277.809+2418262%-518536.099+237599990%
Pe Ratio-12.551-1075%-1.068-1.0680%-152.923+14217%-1013.341+94768%-3070.347+287344%
Peg Ratio---1.007-1.0070%-80.740+7922%-4770.762+473874%-4770.762+473874%
Price Per Share0.005+91%0.0000.0000%0.061-99%2.512-100%56.508-100%
Price To Total Gains Ratio14.941+91%1.2721.2720%131.652-99%-6856.351+539318%-490570.010+38580976%
Profit Growth--1.0611.0610%1.894-44%0.861+23%0.861+23%
Quick Ratio--0.0010.0010%0.001-12%0.001+124%0.000+258%
Return On Assets---3.710-3.7100%-2.418-35%-24.689+566%-16.888+355%
Return On Equity----0%-0%-0%-0%
Revenue Growth--0.3590.3590%1.001-64%0.680-47%0.680-47%
Total Gains Per Share--0.0000.0000%0.000-32%0.000+212%0.000+173%
Total Gains Per Share Growth--0.6790.6790%2.238-70%-0.800+218%-0.175+126%
Usd Book Value---1832818.000-1832818.0000%-2147392.000+17%-1535439.800-16%-1008649.875-45%
Usd Book Value Change Per Share--0.0000.0000%0.000-32%0.000+212%0.000+173%
Usd Book Value Per Share---0.002-0.0020%-0.002+17%-0.002-16%-0.001-45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%0.000+7%-0.002+376%-0.001+244%
Usd Free Cash Flow---349030.000-349030.0000%-446907.000+28%-261612.600-25%-163507.875-53%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+28%0.000+30%0.000+39%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-600%0.000-55%0.000-280%
Usd Price Per Share0.005+91%0.0000.0000%0.061-99%2.512-100%56.508-100%
Usd Profit---374470.000-374470.0000%-398886.000+7%-1781308.400+376%-1289632.000+244%
Usd Revenue--14281.00014281.0000%39795.000-64%18767.400-24%11729.625+22%
Usd Total Gains Per Share--0.0000.0000%0.000-32%0.000+212%0.000+173%
 EOD+4 -1MRQTTM+0 -0YOY+11 -265Y+19 -1810Y+21 -17

3.2. Fundamental Score

Let's check the fundamental score of Premier Biomedical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.551
Price to Book Ratio (EOD)Between0-1-2.564
Net Profit Margin (MRQ)Greater than0-26.222
Operating Margin (MRQ)Greater than0-22.879
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.048
Debt to Asset Ratio (MRQ)Less than119.157
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.710
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Premier Biomedical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.532
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.003
OpenGreater thanClose0.005
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2019-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets101
Total Liabilities1,934
Total Stockholder Equity-1,833
 As reported
Total Liabilities 1,934
Total Stockholder Equity+ -1,833
Total Assets = 101

Assets

Total Assets101
Total Current Assets94
Long-term Assets94
Total Current Assets
Cash And Cash Equivalents 71
Net Receivables 2
Inventory 13
Other Current Assets 7
Total Current Assets  (as reported)94
Total Current Assets  (calculated)94
+/-0
Long-term Assets
Property Plant Equipment 7
Long-term Assets  (as reported)7
Long-term Assets  (calculated)7
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,934
Long-term Liabilities0
Total Stockholder Equity-1,833
Total Current Liabilities
Short Long Term Debt 161
Accounts payable 188
Other Current Liabilities 1,519
Total Current Liabilities  (as reported)1,934
Total Current Liabilities  (calculated)1,868
+/- 66
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock3
Total Stockholder Equity (as reported)-1,833
Total Stockholder Equity (calculated)3
+/- 1,835
Other
Capital Stock5
Common Stock Shares Outstanding 262,111
Net Debt 90
Net Invested Capital -1,674
Net Tangible Assets -1,835
Net Working Capital -1,840



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
43
25
121
48
39
209
165
101
10116520939481212543
   > Total Current Assets 
0
0
116
45
34
204
160
94
94160204344511600
       Cash And Cash Equivalents 
40
16
104
35
22
84
87
71
71878422351041640
       Net Receivables 
0
0
0
0
0
0
3
2
23000000
       Other Current Assets 
0
6
12
0
11
35
44
7
744351101260
   > Long-term Assets 
0
0
0
0
5
5
5
7
75550000
       Property Plant Equipment 
3
3
5
4
5
5
5
7
75554533
> Total Liabilities 
119
274
188
474
700
2,820
2,312
1,934
1,9342,3122,820700474188274119
   > Total Current Liabilities 
119
274
188
474
700
2,820
2,312
1,934
1,9342,3122,820700474188274119
       Short-term Debt 
0
0
15
0
0
0
0
0
000001500
       Short Long Term Debt 
0
0
15
0
183
170
310
161
16131017018301500
       Accounts payable 
107
122
147
188
221
347
264
188
188264347221188147122107
       Other Current Liabilities 
0
43
26
188
268
2,295
1,714
1,519
1,5191,7142,29526818826430
   > Long-term Liabilities 00000000
> Total Stockholder Equity
0
0
-68
-426
-661
-2,611
-2,147
-1,833
-1,833-2,147-2,611-661-426-6800
   Common Stock
0
0
0
1
3
0
0
3
30031000
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
0
0
0
0
0
274
5
0
0527400000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2019-12-31)

Gross Profit (+$)
totalRevenue14
Cost of Revenue-13
Gross Profit11
 
Operating Income (+$)
Gross Profit1
Operating Expense-341
Operating Income-327-340
 
Operating Expense (+$)
Research Development-
Selling General Administrative328
Selling And Marketing Expenses-
Operating Expense341328
 
Net Interest Income (+$)
Interest Income-
Interest Expense-393
Net Interest Income-393-393
 
Pretax Income (+$)
Operating Income-327
Net Interest Income-393
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-374-672
EBIT - interestExpense = -719
-374
18
Interest Expense393
Earnings Before Interest and Taxes (ebit)-32718
Earnings Before Interest and Taxes (ebitda)21
 
After tax Income (+$)
Income Before Tax-374
Tax Provision--
Net Income From Continuing Ops-374-374
Net Income-374
Net Income Applicable To Common Shares-374
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net345393
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ENLT.TA
9 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENLT.TA.

ENLT.TA Daily Candlestick Chart
GBPEUR.FOREX
12 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPEUR.FOREX.

GBPEUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
12 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDIDR.FOREX
12 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDIDR.FOREX.

NZDIDR.FOREX Daily Candlestick Chart
MYRGBP.FOREX
12 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRGBP.FOREX.

MYRGBP.FOREX Daily Candlestick Chart
GBPMYR.FOREX
12 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPMYR.FOREX.

GBPMYR.FOREX Daily Candlestick Chart
GBPIDR.FOREX
12 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPIDR.FOREX.

GBPIDR.FOREX Daily Candlestick Chart
SGDGBP.FOREX
12 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGDGBP.FOREX.

SGDGBP.FOREX Daily Candlestick Chart
GBPSGD.FOREX
12 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPSGD.FOREX.

GBPSGD.FOREX Daily Candlestick Chart
CADNOK.FOREX
12 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CADNOK.FOREX.

CADNOK.FOREX Daily Candlestick Chart
SVRT.TA
13 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVRT.TA.

SVRT.TA Daily Candlestick Chart
PHTM.TA
13 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHTM.TA.

PHTM.TA Daily Candlestick Chart
NICE.TA
13 hours ago

I found you a Golden Cross on the daily chart of NICE.TA.

NICE.TA Daily Candlestick Chart
NFTA.TA
13 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
ICB.TA
13 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ICB.TA.

ICB.TA Daily Candlestick Chart
FRSX.TA
13 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRSX.TA.

FRSX.TA Daily Candlestick Chart
DCMA.TA
13 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DCMA.TA.

DCMA.TA Daily Candlestick Chart
ARD.TA
13 hours ago

I found you a Death Cross on the daily chart of ARD.TA.

ARD.TA Daily Candlestick Chart
MCRNT.TA
15 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart